Technology | 2009.10.27
Lifeline Biotechnologies Reports on FDA Filing Status
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported on the status of the pending FDA submission of its First Warning System™, filed in late July 2009. Jim Holmes, Lifeline\'s CEO, said, "This past July we filed with the FDA to determine if our technology and testing of over 600 patients would meet the requirements for a 510(k). We have checked with our FDA consulting firm, the firm that assisted us with the preparation and submission of our July 20
For more information, please visit
http://www.businesswire.com/news/home/20091026006212/en
Instagram is adding automatic in-app text translation - The Verge views: 1530
Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1527